Quantcast

Latest Alzheimer's Stories

2014-02-20 20:24:06

New platform will link eligible candidates to clinical trials around the world WASHINGTON, Feb. 20, 2014 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease and the New York Academy of Sciences today convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer's Platform (GAP), designed to reduce the time and costs of Alzheimer's clinical trials, develop an infrastructure that promotes innovation,...

2014-02-20 12:27:47

Takeda will advance the CEOi's goal of building global momentum behind the G8's 2025 commitments WASHINGTON, Feb. 20, 2014 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease today announced that Takeda Pharmaceutical Company Limited ("Takeda") will join the CEOi as part of its effort to spur innovations in research and accelerate a means of prevention for Alzheimer's and Dementia, building momentum behind the G8's commitment to stop the disease by...

2014-02-18 12:29:49

Home Instead to advance global momentum triggered by G8 Dementia Summit to improve care for families touched by Dementia WASHINGTON, Feb. 18, 2014 /PRNewswire-USNewswire/ -- The Global CEO Initiative (CEOi) on Alzheimer's Disease today announced that Home Instead Senior Care© - the world's leading provider of in-home care services for seniors will join the CEOi to advance the quality of care for those suffering from Alzheimer's and Dementia. Through its diverse group of leading...

2014-02-12 12:30:19

Eli Lilly, the Sole Competitor in 2013, Will Be Joined by GE Healthcare, Piramal Enterprises and Navidea Biopharmaceuticals in the Next Few Years, According to Findings from Decision Resources Group BURLINGTON, Mass., Feb. 12, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States Alzheimer's imaging agent market will grow dramatically over the next 10 years. Currently, Eli Lilly's Amyvid, launched in June 2013, is the only Food and Drug Administration...

2014-02-07 16:24:27

HARRISBURG, Pa., Feb. 7, 2014 /PRNewswire-USNewswire/ -- Secretary of Aging Brian Duke today presented the Pennsylvania State Plan for Alzheimer's Disease and Related Disorders to Governor Tom Corbett on behalf of the members of the Pennsylvania Alzheimer's Disease Planning Committee, completing the group's year-long process to study the state's response to the disease and develop a plan to address it. Governor Corbett established the 26-member committee by executive order on Feb. 7,...

2014-02-05 12:27:55

Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb. 5, 2014 /PRNewswire-USNewswire/ -- As research unveils overlap in the biology -- in addition to long-noted shared clinical symptoms -- of Parkinson's and Alzheimer's diseases, three non-profit organizations are uniting to encourage further study into the similarities and differences between the two most common brain diseases,...

2014-02-03 12:29:31

Clinical research team meets with principal investigators in St Petersburg as a clinical trial of the first tau aggregation inhibitor (TAI) in Phase 3, aimed at halting the progression of Alzheimer's, gets underway in Russia ALBANY, N.Y., Feb. 3, 2014 /PRNewswire/ -- A doctor-and-nurse team from the Neurological Associates of Albany clinic will travel to St Petersburg, Russia, next month to meet with clinical research doctors about TauRx Therapeutics' global Phase 3 clinical trial...

2014-01-16 20:22:21

WASHINGTON, Jan. 16, 2014 /PRNewswire-USNewswire/ -- An unprecedented $122 million increase for Alzheimer's research, education, outreach and caregiver support stemming from the efforts of Alzheimer's Association advocates was passed swiftly by Congress today. The Alzheimer's Association commends the bipartisan work of our elected officials to make Alzheimer's disease a national priority. Congress has been engaged in addressing Alzheimer's over the last several years, having...

2014-01-09 08:28:04

BOSTON, Jan. 9, 2014 /PRNewswire/ -- Akili Interactive Labs Inc. ("Akili") announced today that it has entered into an agreement with Pfizer Inc. to test the ability of Akili's mobile video game platform ("Project EVO") to detect cognitive differences in healthy elderly people at risk of developing Alzheimer's disease. To Akili's knowledge this is the first time that a large pharmaceutical company will test the use of a mobile video game as a clinical tool to determine early signs of...

2014-01-06 04:21:53

Clinical research centers added to allow more patients to access a tau-based investigational treatment for mild to moderate Alzheimer's disease ABERDEEN, Scotland, Jan. 6, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd, a clinical-stage biopharmaceutical company developing a novel treatment for Alzheimer's disease, has expanded its international clinical trials by adding new research centers across the U.S. The addition of 35 clinical research centers means that more patients suffering...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related